chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Left Shoulder tenderness since she received the flu vaccine on 13 October 2016. Patient reported tender to touch, no arm tingling or numbness, no loss of ROM sensation or strength. Pulses present, vital signs were stable and WNL. Patient was afebrile. Neurovascular exam completed patient intact. R/O SIRVA 12 Jan 2017.
My left upper arm was sore after the injection, but my left shoulder hurt.  I have never had anything like this happen before and I have received vaccinations all my life.  At first, I thought the pain would just go away by the next day, however it didn't and my left arm was also sore.  I gave it a few more days to see if the soreness and pain would just go away on their own.  My arm got better, but my shoulder was very slow in improving.  A friend of mine also had a bad experience with her booster shot and so I called her to see how she was doing.  She received her booster a few months before I got mine.  She had not improved at all and her doctor encouraged her to go to PT.  After talking with my friend, I realized that my pain was not as severe has hers however my pain was bad,  I could move my shoulder, so I concluded that it wasn't frozen, but it popped a lot and it was painful to dress and undress.  If I kept it very still, I felt no pain.  But as soon as I moved it, the pain was immediate.  I called my doctor the end of December.  She recommended OTC pain relief such as Tylenol, ibuprofen, etc.  I tried that but it didn't help.  As time went on, I did notice that the severity of the pain seemed to lessen, so I gave it some more time to see if it would heal on its own.  As of this writing, it has been almost 3 months since I got the booster and my arm has improved, however, I am not back to my normal pain-free self.  The pain has lessened more and the popping is less also, however, dressing an undressing is when I feel it the most.  The pain shoots up from a zero to 8 or 9.  I am SO annoyed with this!  I will never go to a Pharmacy again.  But my big concern now is that I'm scared to ever get another vaccination and if I do, I don't know which arm to use.
Prolonged joint/muscular pain in the left deltoid region, pain shifts around to right arm as well as the leg region . Planning to visit doctor's office soon.
This spontaneous report as received from a healthcare worker refers to a 4 year old patient of unknown gender. Concurrent conditions and medical history were not reported. On 03-SEP-2015, the patient was vaccinated with an improperly stored dose of PROQUAD (Merck) (lot number L010142 and expiration date 24-SEP-2016, therapy type, dose and route of administration were not provided). Concomitant therapy was not reported. No adverse effects were reported. This is one of several reports from the same source. Additional information has been requested.
Post first vax with no untoward effects. Post second dose sometime thereafter, experienced arthritic pain in his lower back, spine, hands, and shoulder. Treatment included Advil.
Pain in left arm when moving or flexing muscle followed by congestion and "head / sinus cold" symptoms, then followed by massive blister on lip, which is something that has never happened before.
Acute respiratory disease  Exposure to SARS-associated coronavirus  COUGH UNRESOOLVED PNEUMONIA
This case was reported by a other health professional via call center representative and described the occurrence of influenza-like symptoms in a 60-year-old female patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced influenza-like symptoms, general body pain, fatigue and nausea. On an unknown date, the outcome of the influenza-like symptoms, general body pain, fatigue and nausea were recovered/resolved. It was unknown if the reporter considered the influenza-like symptoms, general body pain, fatigue and nausea to be related to SHINGRIX. Additional details were provided as follows: This case was reported by a physician assistant (PA). The patient received a dose of SHINGRIX at a pharmacy. The patient experienced flu like symptoms and body ache. She missed 3 days of work. The reporter was unsure when the symptoms were started or resolved. The suspect vaccine lot number, expiry date and the patient's date of birth were unavailable. This case is 1 of the 3 cases, reported by the same reporter.
Patient received moderna bivalent on 9/4 and came back and received another on 10/18. The dose on 9/4 was not reported for some reason but the patient called concerned because they received another dose too soon.
in a contact with a distant relative who tested positive to COVID-19; cough; sore throat; This is a spontaneous report from a contactable consumer (Patient). A 24-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 2 via an unspecified route of administration, administered in Arm Left on 26Jan2021 (Batch/Lot Number: EL3248) as single dose for COVID Prevention (age at vaccination was 24 years). She does have regular allergies, her whole family does, so she gets sick easily and it is not abnormal for her. She had no other vaccines on the same days as her doses of the COVID vaccine. Patient received concomitant therapy. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 1 via an unspecified route of administration, administered in Arm Left on 05Jan2021 (Batch/Lot Number: EL1284) as single dose for COVID-19 immunisation (age at vaccination was 24 years). The patient reported that She explained she was in a contact with a distant relative who tested positive to COVID-19 therefore, she got tested for COVID-19 and spent 10 days in quarantine. She specified her test result came back "inconclusive". She works at a shelter service. Patient got her second dose of the COVID vaccine on 26Jan2021, and last week, patient's husband received a text from his daughter's mom, saying that their house has tested positive for COVID. Patient's husband is in healthcare. They were both fully vaccinated, but her worker put her on quarantine. She went to get tested for COVID on Tuesday of last week and her husband tested negative but her test was inconclusive. Patient stated that a couple days after she got the COVID test, she started with a cough and sore throat on an unknown date in Feb2021 and she had that for a few days. She did also develop a cough and sore throat for a few days following her COVID test. She had her COVID test on 09Feb2021 and it came back inconclusive, she indicated it was not a rapid test, but she does not know the official name for the test she got, it was a drive through nasal swab test. Outcome of events cough and sore throat was recovered on an unknown date in Feb2021.  No follow-up attempts are possible. No further information is expected.
I was fine the day of the vaccine, just a sore arm. The next morning, Saturday, I had a severe headache but was able to take ibuprofen and keep it under control. Sunday, I was fine. On Monday and Tuesday, I had a lot of diarrhea. On Wednesday morning (starting at 4:00 a.m.), I was so dizzy, I was not able to walk safely. The dizziness lasted most of the day. By Thursday morning, the skin on both of my hands were peeling, the entire palms and fingers were peeling. The tips of my fingers and my feet had numbness and tingling (though my feet were not peeling). The peeling only lasted a day but the tingling lasted a couple weeks. All the side effects seem to be gone now.
ULTRASOUND DOPPLER ABNORMAL; ARTHRALGIA; CHILLS; PARAESTHESIA; FATIGUE; NAUSEA; PYREXIA; SUPERFICIAL VEIN THROMBOSIS; TREMOR; PERIPHERAL SWELLING; INJECTION SITE MASS; PAIN; This spontaneous report received from a health care professional via a Regulatory Authority VAERS (Vaccine Adverse Event Reporting System) concerned a 34-year-old female. The patient's height, and weight were not reported. The patient's past medical history included: breastfeeding. The patient received covid-19 vaccine ad26.cov2.s (Janssen series 1, suspension for injection, route of admin not reported, batch number: 042a21a expiry: UNKNOWN) dose was not reported, 1 total, administered on 08-APR-2021 for an unknown indication. Vaccine was given about 1.5 cm below the acromion process per doctor measurement. No concomitant medications were reported. On 08-APR-2021, the patient experienced a small lump at injection site within 15 minutes of vaccination. That night patient had 'pins and needles' (paraesthesia) down her left arm. The patient experienced hand tremors, chills, fever 102.3, nausea, body aches, fatigue and shoulder pain (arthralgia). On 09-APR-2021, The patient took ibuprofen at 4 AM. On 10-APR-2021 patient noticed a lump on her left forearm. On 14-APR-2021, The patient had an Ultrasound Doppler done on her left arm and a supraficial venous thrombosis in the cephalic vein of the left forearm was found. Patient was told to start aspirin 81 mg. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the arthralgia, chills, fatigue, injection site mass, nausea, pain, paraesthesia, peripheral swelling, pyrexia, superficial vein thrombosis, tremor and ultrasound doppler abnormal was not reported. This report was serious (Other Medically Important Condition).  Version created to amend previously reported information on 30-NOV-2021. Upon review following information was amended: seriousness of event superficial vein thrombosis updated to serious (other medically important).; Sender's Comments: V1. This follow up version was created to update the following information: seriousness of event superficial vein thrombosis updated to serious (other medically important).  20211201391-covid-19 vaccine ad26.cov2.s -superficial vein thrombosis . This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
patient was given pediatric dose of hep A, not adult dose for their second dose. Given hep b peds for first dose.
After receiving my first shot I came home and was extremely tired went to bed at 9:30 to sleep immediately and woke up at 2:11 AM with the symptoms of chills vomiting diarrhea fever sore throat massive headache and as of 745 still have all the same symptoms
Lymph Nodes visibly swollen; Pain; This is a spontaneous report from a non-contactable consumer, the patient. A 16-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the right arm on 12Apr2021 at 20:00 (at the age of 16-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021, the patient experienced lymph nodes visibly swollen and pain. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events lymph nodes visibly swollen and pain was recovering at the time of this report.   No follow-up attempts are possible. No further information is expected.
RECIEVED DTAP RIGHT UPPER ARM AT 2:00PM 3-3-03.  LAST NICHT NOTED SWOLLEN PINK AREA SURROUNDED BY PINPOINT RED SPOT AT SITE OF INJECTION. +FEVER; TENDER TO TOUCH; NO RESPIRATORY SYMPTOMS; PE: 70 MM ERYTHEMA RIGHT UPPER ARM, PINPOINT ERETHEMITIOUS LESION CENTRALLY WITH 1MM PALE COLOR SURROUNDING LESION; WARM TO TOUCH; TM'S CLEAR; NECK SUPPLE; CHEST CLEAR; NO WHEEZE; NO RALES; ABD BENIGN.  DTAP REACTION 2ND CELLULITIS.  AUGMENTIN 200 PO BID X 7 DAYS; BENADRYL 8MG PO Q 6-8 HRS; WARM SOAK; RECHECK IN 24HRS.
Had the feeling of a weight on my chest & trouble breathing 4/22/2021. Went to Dr who sent me to Hospital. Later transferred to Hospital to have a Pacemaker implanted by Dr. Just 3 months before I had a perfectly normal EKG.  Now I had complete Left Bundle Branch Block of the heart.
injection arm was bruised, itchy, and had red dots; injection arm was bruised, itchy, and had red dots; injection arm was bruised, itchy, and had red dots; This is a spontaneous report from a contactable consumer, the patient.  A 34-years-old male patient received bnt162b2 (PFIZER BIONTECH COVID 19 VACCINE, formulation: solution for injection, lot number: EW0169) via an unspecified route of administration on 22Apr2021 as dose number unknown, single (age at vaccination 34 years) for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient stated that he received the Pfizer COVID-19 vaccine on 22Apr2021 and after two hour the injection arm was bruised, itchy, and had red dots. It was reported that the event took place after use of product. The outcome of the events was unknown.   The reporter did not wish to be contacted for follow-up.  No follow-up attempts are needed. No further information is expected.
Rash across chest. From arm pit to arm pit, under breasts and down middle about 3 inches toward belly button.
12/29/2020 swollen, red, pain and heat at injection site. Redness has expanded to  6 in long and wide with huge knot. Pt has felt fatigued
Injection site swelling; Fever blister; This case was reported by a pharmacist via call center representative and described the occurrence of injection site swelling in a 91-year-old female patient who received Herpes zoster (Shingrix) (batch number BP57E, expiry date 7th December 2021) for prophylaxis.   On 17th September 2019, the patient received Shingrix (intramuscular). In September 2019, less than a week after receiving Shingrix, the patient experienced injection site swelling and fever blister. On an unknown date, the outcome of the injection site swelling and fever blister were unknown.   It was unknown if the reporter considered the injection site swelling and fever blister to be related to Shingrix.  Additional case details were reported as follows: The patient received vaccine in left deltoid. The patient experienced injection site swelling and a fever blister of the mouth following a dose of Shingrix. The healthcare professional did not provide exact start date or outcome of events. The reporter consented to follow up.
This spontaneous report was received from a registered dietician regarding herself, who was a 75 year old female patient. Patient's concurrent condition included asthma (since past 30 years), chronic obstructive pulmonary disease (COPD) (since past 2 years). Patient has drug reactions or allergies to aspirin which causes bruising and bleeding. On an unknown date in December 2014 the patient was vaccinated with PNEUMOVAX 23 (lot number, dose, frequency and route unspecified), in the left arm. On the same day, the patient was also vaccinated with PREVNAR 13 (dose, frequency and route unspecified) in the right arm. Concomitant therapies included SYNTHROID, SPIRIVA, VENTOLIN, hydrochlorothiazide (manufacturer unknown), NEXIUM, ADVAIR, verapamil, CRESTOR, EVISTA, montelukast sodium (manufacturer unknown), potassium (unspecified), loperamide hydrochloride, benzonatate and albuterol sulfate. On an unknown date the patient experienced continued intermittent itchiness at the PNEUMOVAX 23 injection site. The patient did not sought medical attention. No treatment was given for the adverse events. The outcome of the events was unknown. The causality of the events with PNEUMOVAX 23 was not reported. Product quality issue was not involved. Additional information has been requested.
Patient with 2 Pfizer COVID vaccinations, last dose 04/27/21, who admitted to the hospital with multiple complications including COVID and ultimately admitted to hospice services and died.  Provider discharge note to hospice services below:  "93 YO male that presented to the ED with c/o weakness, altered mental status, poor appetite, and fatigue. Chronic health conditions include pacemaker placement, HFrEF, AFib, CAD, COPD, HTN, and thyroid disease.  Patient was discharged from the hospital on December 9.  He began to seem symptomatic 3 days ago when he be became weak and had fatigue. Today he was found in his room confused, not knowing who his family members were and naked sitting in his own stool.  He had a fall in the last couple of days sustaining a head laceration.  He has become so weak that he cannot walk and he spends most of his day sleeping and not eating meals.  Patient relays that he has had a runny nose and nausea.  Patient denies chest pain or shortness of breath.    In the ED, HGB 11.5, creatinine 1.9 GFR 30, BNP 53,477, CXR shows hazy opacity throughout both lungs, and trace bilateral pleural effusions  COVID positive. (HPI per NP)   Hospital Course: No notes on file HFrEF  home medication includes Lasix 60 mg po daily. Start Lasix 60 IV BID. Strict I&O, daily weights. Fluid and sodium restrict. Repeat BNP Friday.    COVID patient has received his 1st 2 doses of COVID vaccine. Symptoms began 3 days ago. He is not hypoxic and is high risk for progression.    End of life care and placement patient has agreed due to his home circumstances and increasing need for more complicated care that he should accept placement to long-term care facility and would like hospice care as well.  Hospice consulted and family signed up for hospice. Patient remained very weak, dyspneic and debilitated and was admitted to GIP hospice.   Discharge Exam: General - very frail, debilitated, poorly responsive HEENT - NC AT Heart - S1 S2 RRR Lung - moderate air entry Neuro - Unresponsive     Issues Requiring Follow Up: (Who, what, when, and how communicated?) Admitted to GIP hospice"  Patient died on 01/03/22 on hospice services.
pt began to ahve fever the morning following shot 4AUG93; pt was sick & had fever to 103 lasting 5 days; was taken to pvt MD & hosp ER w/cont fever;
pt recv vax 24AUG98 & on 17SEP98 pt exp joint pain w/tenderness bilat in knees, dec ROM & pain to touch;pt also exp metacarpal joint of lt hand;
Patient fainted 1 minute after receiving vaccination. pt was out for 2 second. had bump on head and responded fine after mom picked him up. mom will follow up with pcp Dr
came down with the flu within a week; Initial information received on 05-Feb-2022 regarding an unsolicited valid social media non-serious case received from a consumer/non-hcp.  This case involves Adult and unknown gender patient who came down with the flu within a week while receiving vaccine INFLUENZA VACCINE.  The patient's past medical treatment(s), vaccination(s) and family history were not provided. The patient had no medical history, concomitant disease or risk factor.    On an unknown date, the patient received an unknown dose of suspect INFLUENZA VACCINE (formulation, strength: unknown) produced by unknown manufacturer lot number not reported in unknown administration site for flu. Lot number cannot be requested.  In 1987, 35 years ago, the patient came down with the flu within a week (influenza) (unknown latency) following the administration of INFLUENZA VACCINE.  It was reported" Ah got the flu shot once, came down with the flu within a week !!! That was 35 years ago haven't gotten another shot and haven't had the flu in 35 years so don't bother me with something that doesn't work."  There were no lab data/results available.  Action taken was not applicable.  It was not reported if the patient received a corrective treatment for the event (came down with the flu within a week).  At time of reporting, the outcome was Unknown for the event came down with the flu within a week.
A sudden urge to urinate; Tingling sensation; Felt warm; Feet were sweaty; Hands clammy; Anxious; Antsy; A spontaneous report was received from a pharmacy intern concerning herself, a 34-year-old, female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced a sudden urge to urinate (Micturition urgency), tingling sensation (Paraesthesia), feeling warm (Feeling hot), sweaty feet (Hyperhydrosis), clammy hands (Cold sweat), anxiety and feeling antsy (Restlessness).   The patient's medical history was not provided. Concomitant product use was not provided by the reporter.   On 24-Dec-20, approximately 3 hours prior to the onset of the symptoms, the patient received their first of two planned doses of mRNA-1273 (037A20-A) intramuscularly in the right arm for prophylaxis of COVID-19 infection.   On the same date, a few minutes after the vaccination she was standing up and felt a sudden urge to urinate and a tingling sensation. She did not feel light headed but felt warm. She checked her temperature at the pharmacy, and it was fine. At the pharmacy she sat down and was feeling warm. Her feet were sweaty so she took her shoes off and the feeling went away in 15 to 20 minutes. The patient went home and was still feeling the same way again: warm and hands clammy. She walks around and feels the coolness of the house, but still feels clammy. She checked her axillary temperature and it was 98.5 degrees Fahrenheit. She also feels anxious and antsy. She stated that she is going to reach out to her doctor for treatment advice.  Treatment information was not provided.   Action taken with mRNA-1273 in response to the events was unknown.   The outcome of the event sweaty feet resolved 15-20 minutes after the patient removed her shoes, and the outcome of the events sudden urge to urinate, tingling sensation, feeling warm, clammy hands, anxiety and feeling antsy were not reported.; Reporter's Comments: This case concerns a 34 year old female patient, who experienced the non-serious unlisted events of sudden urge to urinate, tingling sensation, feeling warm, sweaty feet, clammy hands, anxiety, and feeling antsy . The events occurred on the same day after receiving the first dose of mRNA-1273 vaccine.  Based on the current available information and temporal association between vaccination and the onset of events on the same day, a causal relationship cannot be excluded.
Cough started Sunday 7/9. Itchy, scratchy, dry left eye started 7/8. Visited ophthalmologist on 7/11 and was diagnosed with pink eye. I think it could be case of ophthalmic shingles. I didn't think to tell them I had had the Shingles immunization but I will tomorrow 7/14.
Patient with PMH significant for OSA, obesity, GAD, MDD, ADHD who was admitted on 11/25 due to cough, shortness of breath. She presented with 1 week of URI symptoms with non-productive cough. Work up in the ED including CT angio of the chest showed mild to moderate pneumomediastinum, no PE, minimal ground glass opacity in the lung bases, started her on Prednisone 40mg daily x 5 days and albuterol prn inhaler. Discharged after 2 days. ED visit and hospital admission within 6 weeks of receiving the COVID vaccine.
Information has been received from a senior technician certified concerning a patient who was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine. Subsequently, the patient developed raised, hot, tender lump at the injection site. At the time of the report, the patient's outcome was known. Additional information has been requested.